Average Co-Inventor Count = 4.00
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Arrien Pharmaceuticals LLC (14 from 14 patents)
2. University of Utah Research Foundation (13 from 1,644 patents)
3. University of Arizona (6 from 972 patents)
4. Supergen, Inc (6 from 52 patents)
5. Stingray Therapeutics, Inc. (3 from 5 patents)
6. Convergene, LLC (3 from 5 patents)
7. Montigen Pharmaceuticals, Inc. (3 from 3 patents)
8. Tolero Pharmaceuticals, Inc. (2 from 21 patents)
9. Astex Pharmaceuticals, Inc. (2 from 11 patents)
10. Beta Cat Pharmaceuticals, Inc. (2 from 3 patents)
11. Other (1 from 832,680 patents)
12. Sumitomo Dainippon Pharma Oncology, Inc. (1 from 11 patents)
13. Navigen, Inc. (1 from 5 patents)
14. The Rockefeller University (712 patents)
15. Sumitomo Pharma Oncology, Inc. (11 patents)
50 patents:
1. 11407729 - Quinoline and quinazoline compounds and methods of use thereof
2. 11142524 - Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics
3. 11053221 - Substituted pyrimidines for inhibiting embryonic leucine zipper kinase activity
4. 10849901 - Arf6 inhibitors and methods of synthesis and use thereof
5. 10752594 - JAK1 and ALK2 inhibitors and methods for their use
6. 10717739 - Methods and compositions for inhibition of bromodomain-containing proteins
7. 10689376 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics
8. 10682358 - Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
9. 10266536 - Methods and compositions for inhibition of bromodomain-containing proteins
10. 10202356 - JAK2 and ALK2 inhibitors and methods for their use
11. 10172866 - Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
12. 9963475 - Anthracene-9, 10-dione dioxime compound prodrugs and their uses
13. 9962382 - Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
14. 9951062 - Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
15. 9890153 - Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors